1. Krawczak M, Cooper DN: The human gene mutation database. Trends Genet 1997; 13: 121-122.

2. Rosler A, Leiberman E: In: Adrenal diseases in childhood: pathophysiologic and clinical aspects, New MI, Levine LS, eds. vol 13. S. Karger, Basel, 1984; 47-71.

3. Zachmann M, Tassinari D, Prader A: Clinical and biochemical variability of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Endocrinol Metab 1983; 56: 222-229.

4. Cerame BI, Newfield RS, Wilson RC et al. Prenatal diagnosis and treatment of 11 beta-hydroxylase deficiency congenital adrenal hyperplasia. In: New, MI (ed) Diagnosis and treatment of the unborn child. Idelson-Gnocchi Ltd. Reddick, FL. 1999; 175-178.

5. Sutherland DJ, Ruse JL, Laidlaw JC. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by Dexamethasone. Can Med Assoc J. 1966; 95:1109-1119.

6. Dluhy R, Lifton R: Glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 1999; 84(12): p4341-4.

7. Lifton R, Dluhy R, Powers M, et al.: A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992; 355(6357): p262-5.

8. New MI, Levine LS, Biglieri EG, Paeira J, Ulick S.: Evidence for an unidentified ACTH-induced steroid hormone causing hypertension. J Clin Endocrinol Metab 1977; 44:924-933.

9. Krozowski ZS, Baker E, Obeyesekere V, Callen DF: Localization of the gene for human 11b-hydroxysteroid dehydrogenase type 2 enzyme to chromosome 16q22. Cytogenet Cell Genet 1995; 71: 124-125.

10. Dave-Sharma S, Wilson RC, Harbison MD, et al.: Extensive Personal Experience: Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endo Metab 1998; 83: 2244-2254.

11. Conn JW, Potassium Losing Nephritis. Br Med J. 1954; 2: 1415-1416.

12. Gordon R, Stowasser M, Tunny T, Klemm S, Finn W, Krek A: Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin Exp Pharmacol Physiol 1991; 18(5): p283-6.

13. Stowasser M, Gunasekera T, Gordon R: Familial varieties of primary aldosteronism [In Process Citation]. Clin Exp Pharmacol Physiol 2001; 28(12): p1087-90 .

14. Nakajin S, Shinoda M, Haniu M, Shively JE, Hall PF: C-21 Steroid side-chain cleavage enzyme from porcine adrenal microsomes. J Biol Chem 1984; 259:3971

15. Fan Y-S, Sasi R, Lee C, Winter JSD, Waterman MR, Lin CC,: Localization of the human CYP-17 gene (cytochrome P45017a) to 10q24.3 by florescence in situ binding and simultaneous chromosome banding. Genomics 1992; 14:1110-1111.

16. Dubois R, Chappuis J: [Pheochromocytoma: pediatric features]. Arch Pediatr 1997; 4(12): p1217-25.

17. Mircescu H, Wilkin F, Paquette J, et al.: Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease. J Pediatr 2001; 138(2): p269-73.

18. Fonseca V, Bouloux P: Phaeochromocytoma and paraganglioma. Baillieres Clin Endocrinol Metab 1993; 7(2): p509-44.

19. Ross J: Pheochromocytoma. Special considerations in children. Urol Clin North Am 2000; 27(3): p393-402.

20. Khafagi F, Shapiro B, Fischer M, Sisson J, Hutchinson R, Beierwaltes W: Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med 1991; 18(3): p191-8.

21. Magiakou M, Mastorakos G, Oldfield E, et al.: Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994; 331(10): p629-36.

22. Savage M, Lienhardt A, Lebrethon M, et al.: Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 2001; 55 Suppl 1: 24-30.

23. Gomez-Sanchez C: Cushing's syndrome and hypertension. Hypertension 1986; 8(3): p258-64.

24. Mantero F, Boscaro M: Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 1992; 43(5): 409-13.

25. Cassar J, Loizou S, Kelly WF, et al. Deoxycorticosterone and aldosterone excretion in Cushing's syndrome. Metabolism 1980; 29:115-119.

26. Pirpiris M, Yeung S, Dewar E, Jennings G, Whitworth J: Hydrocortisone-induced hypertension in men. The role of cardiac output. Am J Hypertens 1993; 6(4): p287-94.

27. Torpy D, Stratakis C, Chrousos G: Hyper- and hypoaldosteronism. Vitam Horm 1999; 57: 177-216.

28. Klein I: Thyroid hormone and the cardiovascular system. Am J Med 1990; 88(6): p631-7.

29. Woeber K: Thyrotoxicosis and the heart. N Engl J Med 1992; 327(2): p94-8.